AI-Designed DNA Vaccine Triggers Broad Antibodies in 1st Human Trial
Updated
Updated · Singularity Hub · Jul 7
AI-Designed DNA Vaccine Triggers Broad Antibodies in 1st Human Trial
3 articles · Updated · Singularity Hub · Jul 7
Summary
First-in-human testing found the AI-designed DNA vaccine was safe, well tolerated and able to trigger antibodies that recognized multiple sarbecoviruses, the virus family behind SARS and Covid.
Thousands of viral genomes fed the design: researchers at the University of Cambridge used AI to identify conserved features shared across sarbecoviruses, aiming for protection that holds up as variants mutate.
DNA technology could ease deployment because it is more stable than mRNA and can be delivered needle-free through the skin, reducing cold-chain and administration hurdles.
Immune responses were still modest, and researchers said larger trials must show how long protection lasts, whether boosters are needed and whether the vaccine actually prevents infection.
A universal vaccine remains years away, but the study points to a broader strategy for variant-proof shots against coronaviruses, flu and other emerging outbreak threats.
AI designed a 'variant-proof' vaccine, but will its modest immune response be strong enough to stop the next pandemic?
If AI can now design vaccines, could it also predict and neutralize the next major pandemic threat before it even emerges?
AI-Designed Universal DNA Vaccine Completes First Human Trial: A New Era in Pandemic Preparedness and Global Health Equity
Overview
The first human trial of an AI-designed DNA vaccine marks a breakthrough in vaccine development, using artificial intelligence to create a universal vaccine targeting the broad family of Sarbeco coronaviruses. By analyzing all available genetic sequence data with advanced machine learning, researchers designed a 'super antigen' that aims to provide wide-ranging protection against both current and future coronavirus threats. This innovative approach signals a new era in immunization, offering hope for more effective pandemic prevention and demonstrating the powerful role of AI in advancing global health solutions.